391
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:March 4, 2015Terminated
First in Human: 7278 Clinical Trials, Page 40 of 728
Hide Studies Not Open or Pending
392
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors
Condition(s):Advanced Tumors; Melanoma; Non-Small-Cell Lung Cancer; Erdheim-Chester Disease; Other RAS/RAF/MEK/ERK Mutated TumorsLast Updated:September 22, 2022Recruiting
393
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Condition(s):Breast Cancer; Pancreas Cancer; Prostate Cancer; Lung Cancer; Colon Cancer; Esophagus Cancer; Liver Cancer; Ovary Cancer; Advanced or Metastatic Treatment-refractory Solid Tumor MalignanciesLast Updated:December 22, 2020Completed
394
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
Condition(s):Cognitive DisordersLast Updated:August 3, 2022Completed
395
TR1801-ADC in Patients With Tumors That Express c-Met
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:November 1, 2022Active, not recruiting
396
Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet)
Condition(s):LGMDLast Updated:October 24, 2022Not yet recruiting
397
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Condition(s):HER2-positive; Adenocarcinoma; Bile Duct Cancer; Biliary Tract Cancer; Bladder Cancer; Breast Cancer; Breast Neoplasm; Carcinoma, Ductal; Carcinoma, Hepatocellular; Cancer; Lung Cancer, Non-Small-Cell; Carcinoma, Ovarian Epithelial; Carcinoma, Small Cell; Carcinoma, Squamous; Carcinoma, Transitional Cell; Colorectal Cancer; Esophagogastric Junction Neoplasms; Inflammatory Breast Cancer; Stomach Neoplasms; Malignant Neoplasms; Ovarian Neoplasms; Pancreatic Cancer; HER2-positive Solid Tumors; HER2-positive Breast Cancer; HER2-positive Gastric Cancer; HER-2 Protein Overexpression; HER-2 Gene Amplification; Prostate Cancer; Head and Neck Cancer; Endometrial Cancer; Lung Cancer, Small CellLast Updated:December 19, 2022Recruiting
398
Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:December 5, 2022Recruiting
399
Phase I Clinical Trial of a Candidate HPV Vaccine
Condition(s):Human Papillomavirus InfectionLast Updated:January 6, 2023Not yet recruiting
400
TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88)
Condition(s):Advanced Cancer; Advanced Solid Tumor; Cancer; OncologyLast Updated:February 8, 2023Recruiting